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The first fatal Rickettsia rickettsii infection was diag-
nosed in the southwest of Mexico. The patient had fever,
erythematous rash, abdominal pain, and severe central
nervous system involvement with convulsive crisis. The
diagnosis of R. rickettsii infection was established by
immunohistochemistry and specific polymerase chain
reaction. 
F
ive spotted fever group (SFG) rickettsioses have been
documented in the Western Hemisphere: Rocky
Mountain spotted fever (RMSF) (Rickettsia rickettsii),
fleaborne spotted fever (R. felis), rickettsialpox (R. akari),
African tick-bite fever (R. africae), and infection with R.
parkeri.  R. rickettsii infections have been identified in
southern Canada, the United States, northern Mexico,
Costa Rica, Panama, Brazil, and Argentina (1–5). R. felis
has been detected in humans, Ctenocephalides fleas, and
opossums in the United States, Mexico, Brazil, Uruguay,
and Peru (6–9); R. parkeri in the United States, Uruguay,
and Brazil (10); R. africae on islands of the Caribbean Sea;
and R. akari in the United States. Among these agents,
only R. rickettsii is known to cause fatal infections. The
only SFG rickettsial agent previously documented to cause
human infections in the Yucatán Peninsula of Mexico,
where >5% of the population have antibodies to SFG rick-
ettsiae, is R. felis, which is present in 20% of cat fleas
(Ctenocephalides felis) (7,11). Previously, Rocky
Mountain spotted fever had been recognized mainly in
northern Mexico, beginning in the 1940s (Figure 1). We
report a case of fatal RMSF in a previously healthy child
in southwestern Mexico, where this infection had not pre-
viously been recognized. The case may herald the reemer-
gence of RMSF throughout the Americas or be evidence of
a misdiagnosed disease in Latin America.
The Case
In August 2004, a previously healthy girl, age 4 years
and 9 months, was found with 2 ticks attached to her left
ear lobe 3 days before the onset of fever and headache. She
was treated with amoxicillin and had a progressively
severe illness with fever, abdominal pain, headache,
fatigue, diarrhea, nausea, vomiting, cutaneous paresthe-
sias, myalgia, rigidity of the left arm and both legs, and an
erythematous rash involving the extremities and thorax. At
the site of tick attachment on the left ear, an eschar was
observed in association with tender regional lym-
phadenopathy at the time of admission. Clinical laboratory
evaluation showed elevated serum urea and hepatic
transaminase concentrations and neutrophil leukocytosis.
Thrombocytopenia was not reported. On day 7 of illness,
seizures developed, and the patient died.
All research was approved by the ethics committee of
the Faculty of Medicine, Universidad Autonoma de
Yucatán. Necropsy showed cerebral edema and hemor-
rhages in the pleura, lungs, pericardium, endocardium, and
gastric mucosa. Histopathologic examination demonstrat-
ed many lesions of lymphohistiocytic vasculitis, character-
istic of rickettsial infection. Immunohistochemical staining
performed with specific monoclonal antibodies against
SFG lipopolysaccharide as described previously (4) iden-
tified SFG rickettsiae in vascular endothelial cells in mul-
tiple foci in the brain, lung, spleen, and liver (Figure 2).
The patient lived in an urban area where many dogs and
sheep also lived. Two months before the onset of the
patient’s illness, seizures developed in a dog and a sheep
belonging to the family; both died.
DNAwas extracted from paraffin-embedded spleen and
formaldehyde-fixed liver, lung, and brain tissue by
DNeasy Tissue kit (Qiagen, Valencia, CA, USA) as previ-
ously described. Polymerase chain reaction (PCR) ampli-
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Figure 1. Map of Mexico showing the period and regions where
human cases caused by Rickettsia rickettsii were detected.fication of the extracted DNA used genus-specific primers
for the rickettsial 17-kDA protein gene, 5′-TGTCTAT-
CAATTCACAACTTGCC-3′ and 5′-GCTTACAAAAT
TCTAAAAACCATATA-3′. The fragment was cloned into
the TPO TA pCR 2·1-TOPO vector (Invitrogen, Frederick,
MD, USA), and selected clones from the same cloning
reaction were sequenced 3 times with a ABI Prism 377
automated sequencer (Perkin Elmer, Foster City, CA,
USA), and the sequences were compared to those in the
GenBank database by using the Basic Local Alignment
Search Tool at the National Center for Biotechnology
Information (12). Two clones (GenBank accession no.
DQ176856) identified the DNA sequence of the 434-bp
product as R. rickettsii (GenBank accession no.
AY281069), which differed by only 1 nucleotide.
Conclusions
The first documentation of RMSF in southwestern
Mexico reflects, in part, the development of a regional
research laboratory with knowledge and interest in rick-
ettsiology, a situation that is lacking in most parts of Latin
America. However, this finding may also represent an
early warning of widespread reemergence of RMSF. In the
United States, 2 large waves of emergence of RMSF have
been documented during the last century; peaks were seen
in the mid-1940s and early 1980s. In 2004, a total of 1,514
cases of RMSF were reported, the highest number ever in
a single year, including an outbreak in Arizona, where very
few cases had been diagnosed previously (13).
The recent diagnosis of the first cases of RMSF in
Argentina (5), reemergence of RMSF in large clusters with
a case-fatality ratio of 50% in Brazil (4), and reemergence
of isolation-documented fatal RMSF in Colombia suggest
that the factors responsible for the increased incidence are
widespread. This phenomenon was noted for the parallel
reemergence of RMSF and Mediterranean spotted fever
during the 1970s and 1980s (14). The ecologic and epi-
demiologic factors responsible for the periodically
increased transmission of R. rickettsii from ticks to
humans have not been determined.
Most aspects of this fatal case are typical of RMSF: tick
bite, illness in a dog at the residence, disseminated lym-
phohistiocytic vasculitis, acute renal failure, and fatal
seizures associated with cerebral rickettsial endothelial
infection, increased vascular permeability, and cerebral
edema. However, other features are unusual for RMSF.
Although eschars are common in most SFG rickettsioses,
they have seldom been documented in RMSF (15). Despite
the hypothetical spread of SFG rickettsiae from the site of
tick feeding through lymphatic vessels to regional lymph
nodes, regional lymphadenopathy is not a typical feature
of RMSF. Moreover, hemorrhages are not a prominent fea-
ture in most cases of RMSF in North America, compared
with reports of severe hemorrhages in cases from Brazil.
Whether such clinical and pathologic differences are real
or not remains to be determined as well as their potential
association with genetic differences in rickettsial virulence
factors or host factors, including deleterious effects of
medications taken early in the course of illness. 
This case illustrates the major deficiency in controlling
RMSF, the lack of a diagnostic test that is effective early in
the course and widely available. Patients seldom have anti-
bodies to R. rickettsii when they are first seen by a clini-
cian. PCR detection of rickettsial DNA in blood is
insensitive, particularly early in the course. Diagnostic
immunohistochemistry and PCR are available in only a
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Figure 2. Immunohistochemical stain shows spotted fever group
rickettsia in endothelial cells of a blood vessel in brain (top panel)
and lung (bottom panel).few reference laboratories. Timely consideration of the
diagnosis and empiric treatment with doxycycline are the
best that can be achieved in most settings in Mexico, the
United States, or elsewhere.
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